052078

CTLA-4, Ipilimumab Biosimilar (HRP)

Größe

£754.00

SKU:: 052078
Reinheit:: Purified
Lagerbedingungen:: -20°C
Hersteller:: United States Biological
Host:: Human
Immunogen:: Recombinant protein corresponding to human CTLA-4, expressed in CHO cells
Format:: Supplied as a liquid iin PBS, pH 7.2- 7.4, 1% BSA. Labeled with horseradish peroxidase (HRP).
Weitere Details:: Ipilimumab is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. Ipilimumab is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary). Applications: Suitable for use in ELISA and Flow Cytometry.. Other applications not tested. Recommended Dilution: Optimal dilutions to be determined by the researcher. Storage and Stability: Store product at 4°C if to be used immediately within two weeks. For long-term storage, aliquot to avoid repeated freezing and thawing and store at -20°C. Aliquots are stable at -20°C for 12 months after receipt. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Note: Sodium azide is a potent inhibitor of peroxidase and should not be added to HRP conjugates. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.